Figure 4:
Kaplan-Meier curves. (A) Group of patients with Barcelona Clinic Liver Cancer (BCLC) B or C cancers. (B) Survival curve after reassignment of patients with BCLC C cancers with an enhancing tumor volume (ETV) of less than 65 cm3 to BCLC Bn compared with the remaining high–tumor burden BCLC Cn group. (C) Survival curve after reassignment of patients with BCLC C cancers with enhancing tumor burden of less than 4% to BCLC Bn. Patient reallocation based on either ETV of less than 65 cm3 or enhancing tumor burden of less than 4% resulted in a greater separation of the survival curves than the original separation achieved based on conventional BCLC classification.